AI-based Customized tDCS for Finger Motor Recovery After Subacute Stroke

NCT07491029 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2026-03-24

No results posted yet for this study

Summary

The goal of this clinical study is to evaluate whether AI-based customized transcranial direct current stimulation (tDCS) using MR images is more effective than sham stimulation in improving finger motor function in patients with finger paralysis caused by subacute stroke. The main questions it aims to answer are:

* Does AI-based customized tDCS improve finger motor function compared with sham stimulation?
* What medical problems or adverse events occur when participants receive AI-based customized tDCS?

Researchers will compare AI-based customized tDCS with sham stimulation (a look-alike stimulation that delivers no electrical current) to determine whether the intervention improves finger motor recovery in patients with subacute stroke.

Conditions

  • Subacute Stroke
  • Upper Extremity Function

Interventions

DEVICE

AI-based Customized transcranial Direct Current Stimulation

Transcranial direct current stimulation (2 mA for 30 minutes) will be delivered using electrode positions optimized by an AI-based simulation based on each participant's MR images to target the motor cortex.

DEVICE

Sham transcranial Direct Current Stimulation

Transcranial direct current stimulation (0 mA for 30 minutes) will be delivered using electrode positions optimized by an AI-based simulation based on each participant's MR images.

Sponsors & Collaborators

  • Severance Hospital

    collaborator OTHER
  • Asan Medical Center

    collaborator OTHER
  • Bucheon St. Mary's Hospital

    collaborator OTHER
  • Samsung Medical Center

    collaborator OTHER
  • National Rehabilitation Center, Seoul, Korea

    collaborator OTHER_GOV
  • National Health Insurance Service Ilsan Hospital

    collaborator OTHER
  • NEUROPHET

    lead INDUSTRY

Principal Investigators

  • Deog Young Kim · Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-07-31
Completion
2027-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07491029 on ClinicalTrials.gov